LifeScience Biologics
IMPACT Therapeutics’ Senaparib Gains NMPA Approval as First-Line Maintenance Therapy for Advanced Ovarian Cancer
IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthet...
January 17, 2025 | News
Takara Bio Expands Spatial Genomics Portfolio with Curio Bioscience Acquisition
Takara Bio USA Holdings, announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics. This strategic acquisition c...
January 16, 2025 | News
ImmunityBio Advances Marketing Authorization Applications for BCG-Unresponsive NMIBC CIS in Europe and the UK
Marketing authorization application for BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in situ (CIS) submitted to Europ...
January 16, 2025 | News
Lyndra Partners with Thermo Fisher to Drive Phase 3 Trials and Commercial Manufacturing of Long-Acting Oral Therapies
Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra...
January 16, 2025 | News
Iconovo and Lonza Join Forces to Develop Intranasal Biologic for Obesity Treatment
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancemen...
January 15, 2025 | News
Advanced Genomics APAC and Cancer Precision Medicine Partner to Launch GALEAS™ Bladder Cancer Screening Test in Japan
Advanced Genomics APAC Co., Ltd. (hereinafter referred to as "Advanced Genomics APAC," headquartered in Taiwan, Managing Director: Andy Chang) i...
January 14, 2025 | News
CARsgen Therapeutics Administers First Dose of Allogeneic CAR T-Cell Therapy KJ-C2219 in Investigator-Initiated Trial
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
January 14, 2025 | News
Simcere Zaiming and AbbVie Partner to Advance Novel Trispecific Antibody for Multiple Myeloma Treatment
Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement ...
January 14, 2025 | News
Telix Pharmaceuticals Acquires ImaginAb’s Biologics Platform and Therapeutics Pipeline to Advance Precision Radiopharmaceuticals
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, "Telix" or "the Company") today announced the acquisition of a next-generation therapeutics pipeline ...
January 13, 2025 | News
Complete Genomics Strengthens U.S. Manufacturing Footprint and Expands NGS Capabilities Amid Strategic Collaborations and Innovations
Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify i...
January 13, 2025 | News
SN BioScience Secures FDA IND Clearance for SNB-101 Phase 1b/2 Trial, Targeting Extensive Stage Small Cell Lung Cancer
SN BioScience announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administra...
January 13, 2025 | News
Sciwind Biosciences Partners with Verdiva Bio in $2.4 Billion Deal to Advance Global Metabolic Disease Therapies
Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, ...
January 13, 2025 | News
JW Therapeutics' Carteyva® Secures Breakthrough Therapy Designation in China for Relapsed/Refractory Large B-Cell Lymphoma
W Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing ce...
January 13, 2025 | News
Kelun-Biotech and Harbour BioMed Ink $970 Million Licensing Deal with Windward Bio for Anti-TSLP Antibody
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (togeth...
January 13, 2025 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
